Results 241 to 250 of about 178,517 (322)

MicroRNA‑425 inhibits proliferation of chronic lymphocytic leukaemia cells through regulation of the Bruton's tyrosine kinase/phospholipase Cγ2 signalling pathway

, 2020
Jianying Chen, Yuhua Li, Xiaoling Xie
openalex   +2 more sources

FDA-approved small-molecule kinase inhibitors [PDF]

, 2015
Clausen, Mads Hartvig, Nielsen, Thomas E., Wu, Peng   +2 more
core   +1 more source

Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex–Mediated Inflammatory Arthritis

, 2016
Lindsay E. Nyhoff, Bridgette L. Barron, Elizabeth Johnson, Rachel H. Bonami, Damián Maseda, Benjamin A. Fensterheim, Wei Han, Timothy S. Blackwell, Leslie J. Crofford, Peggy L. Kendall   +9 more
openalex   +1 more source

Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling

Molecular Pharmacology, 2017
Andrew T. Bender, A. Gardberg, A. Pereira, Theresa L. Johnson, Yin Wu, R. Grenningloh, J. Head, F. Morandi, P. Haselmayer, L. Liu-Bujalski   +9 more
semanticscholar   +1 more source

PROTAC for Bruton's tyrosine kinase degradation alleviates inflammation in autoimmune diseases. [PDF]

Cell Discov
Zhu C, Yang Z, Zhang Y, Li Z, Li G, Yang B, Kang N, Wang J, Sun Y, Ding N, Rao Y, Liu W.   +11 more
europepmc   +1 more source

Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia

, 2016
PEI-PEI LI, Kang Lu, Lingyun Geng, Xiangxiang Zhou, XIN-YU LI, Xin Wang   +5 more
openalex   +2 more sources

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib [PDF]

, 2016
Advani, Bohers, Cao, Cao, Cheng, Chng, Christopher J. Patterson, Evans, Farré, Gay, Guang Yang, Gutiérrez, Hallek, Hanke, Hong, Honigberg, Janz, Jennifer R. Brown, Jiaji G. Chen, Jie Chen, Jorge J. Castillo, Jourdan, Juilland, Lam, Leleu, Li Tan, Lian Xu, Messeguer, Musumeci, Nathanael Gray, Ngo, Nicholas Tsakmaklis, O’Boyle, Patricelli, Pecquet, Pene-Dumitrescu, Philip Cohen, Poh, Sahota, Saito, Sanner, Sara J. Buhrlage, Schaeffer, Shuai Liu, Steven P. Treon, Suh, Taguchi, Treon, Treon, Treon, Trott, Varettoni, Wei Zhang, Wilson, Woyach, Xia Liu, Xiaofeng Zhang, Xu, Yang, Yang, Zachary R. Hunter   +60 more
core   +2 more sources

The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas. [PDF]

Int J Mol Sci
Mehra S, Nicholls M, Taylor J.
europepmc   +1 more source

Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment

, 2018
Theresa H. Page, Anna Urbaniak, Ana Isabel Espirito Santo, Lynett Danks, Timothy Smallie, Lynn Williams, Nicole J. Horwood   +6 more
openalex   +1 more source

Fenebrutinib, a Bruton's tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. [PDF]

J Neuroinflammation
Langlois J, Lange S, Ebeling M, Macnair W, Schmucki R, Li C, DeGeer J, Sudharshan TJJ, Yong VW, Shen YA, Harp C, Collin L, Keaney J.   +12 more
europepmc   +1 more source